<SEC-DOCUMENT>0001628280-23-002417.txt : 20230206
<SEC-HEADER>0001628280-23-002417.hdr.sgml : 20230206
<ACCEPTANCE-DATETIME>20230206160257
ACCESSION NUMBER:		0001628280-23-002417
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230206
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230206
DATE AS OF CHANGE:		20230206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARROWHEAD PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000879407
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460408024
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38042
		FILM NUMBER:		23590653

	BUSINESS ADDRESS:	
		STREET 1:		177 E COLORADO BLVD
		STREET 2:		SUITE 700
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91105
		BUSINESS PHONE:		626-696-4702

	MAIL ADDRESS:	
		STREET 1:		177 E COLORADO BLVD
		STREET 2:		SUITE 700
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARROWHEAD RESEARCH CORP
		DATE OF NAME CHANGE:	20040112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE GROUP INC
		DATE OF NAME CHANGE:	20020509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>arwr-20230206.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:f39ea126-5149-4ac1-b527-7ebd56cbc4f4,g:c164d589-8486-4fb3-8040-3ae80947f032,d:03e92b0017504cd9b3490ee50ed3b498--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>arwr-20230206</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF80L2ZyYWc6NDRhYWFhMGFjNzc2NDA2Y2FjMGUwOGUyODc3NDE5M2QvdGFibGU6N2FlMjAxYjJiNzA3NDAwZmExNmQ0NzQ5NTExZmE1MDkvdGFibGVyYW5nZTo3YWUyMDFiMmI3MDc0MDBmYTE2ZDQ3NDk1MTFmYTUwOV8yLTEtMS0xLTI5MTUz_2c763a82-b951-4517-bde3-a4ff3eff8a58">0000879407</ix:nonNumeric><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF80L2ZyYWc6NDRhYWFhMGFjNzc2NDA2Y2FjMGUwOGUyODc3NDE5M2QvdGFibGU6N2FlMjAxYjJiNzA3NDAwZmExNmQ0NzQ5NTExZmE1MDkvdGFibGVyYW5nZTo3YWUyMDFiMmI3MDc0MDBmYTE2ZDQ3NDk1MTFmYTUwOV8zLTEtMS0xLTI5MTUz_626c938e-f6e1-4eeb-8378-5767b43556fa">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="arwr-20230206.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000879407</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-06</xbrli:startDate><xbrli:endDate>2023-02-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i03e92b0017504cd9b3490ee50ed3b498_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:115%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">WASHINGTON, D.C. 20549 </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.878%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjE5_cf211cec-7871-4cf6-88af-e977c38530b2">8-K</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.878%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">PURSUANT TO SECTION 13 OR 15(D) OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xODM_a58c757b-7434-4822-9ce8-67313166257f">February 6, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Date of Report </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Date of earliest event reported)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.878%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjI2_fa7c7de5-e190-4ba8-9012-0092dd22146e">Arrowhead Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact name of registrant as specified in its charter) </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.878%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:31.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODcyZWVmMjlkNmE0NDI5N2FhNjdjMTBiZTZkYzQ1NWMvdGFibGVyYW5nZTo4NzJlZWYyOWQ2YTQ0Mjk3YWE2N2MxMGJlNmRjNDU1Y18wLTAtMS0xLTI5MTUz_47d958f9-bfb0-401c-88da-776e8680f6e7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODcyZWVmMjlkNmE0NDI5N2FhNjdjMTBiZTZkYzQ1NWMvdGFibGVyYW5nZTo4NzJlZWYyOWQ2YTQ0Mjk3YWE2N2MxMGJlNmRjNDU1Y18wLTItMS0xLTI5MTUz_e9ec602c-882f-4789-acf8-5d9e45eee9aa">001-38042</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODcyZWVmMjlkNmE0NDI5N2FhNjdjMTBiZTZkYzQ1NWMvdGFibGVyYW5nZTo4NzJlZWYyOWQ2YTQ0Mjk3YWE2N2MxMGJlNmRjNDU1Y18wLTQtMS0xLTI5MTUz_7206f19b-ddcc-4bbb-8269-043b6c6857f9">46-0408024</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjIw_2b4e8f08-53cb-49ec-91ca-fad19d683a25">177 E. Colorado Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjMy_8d7531c8-fe1c-4d07-b05d-8deaf34da5e9">Suite 700</ix:nonNumeric>, <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjI3_826ff097-00c1-471f-930b-ea4435add41a">Pasadena</ix:nonNumeric>, <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjE4_d053b4bf-4594-4178-b8d0-98e33263a0ab">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8zODE_9ea22be3-8db9-4649-ab3b-e0aae537bbe8">91105</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Address of principal executive offices, including Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl80NDY_26144428-d561-4234-8a68-06ead0341076">626</ix:nonNumeric>) <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjI5_13b28c47-c208-432b-a332-bb08a222e3fc">304-3400</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.878%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8wLTAtMS0xLTI5MTUz_3e583bc0-1d50-429d-bd1f-1e855354dc8b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;text-indent:-24pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8xLTAtMS0xLTI5MTUz_f13e819d-72a5-4ac3-9cdf-3f30f3ea9cd0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;text-indent:-24pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8yLTAtMS0xLTI5MTUz_136ea854-579a-4ed3-903d-f8828db2a942">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;text-indent:-24pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8zLTAtMS0xLTI5MTUz_36a27d15-6283-4e03-9e6b-57628adfce80">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;text-indent:-24pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 2.78pt;text-align:center;text-indent:-0.8pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6YmRjYWFhMzg4MDFhNDU5ZTk1NzI1YTdiYWJjNTJhY2IvdGFibGVyYW5nZTpiZGNhYWEzODgwMWE0NTllOTU3MjVhN2JhYmM1MmFjYl8yLTAtMS0xLTI5MTUz_44a93c3d-165f-458b-9b90-76e16ede6727">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6YmRjYWFhMzg4MDFhNDU5ZTk1NzI1YTdiYWJjNTJhY2IvdGFibGVyYW5nZTpiZGNhYWEzODgwMWE0NTllOTU3MjVhN2JhYmM1MmFjYl8yLTItMS0xLTI5MTUz_fd752f2d-3edc-490a-8d30-66a26f225481">ARWR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6YmRjYWFhMzg4MDFhNDU5ZTk1NzI1YTdiYWJjNTJhY2IvdGFibGVyYW5nZTpiZGNhYWEzODgwMWE0NTllOTU3MjVhN2JhYmM1MmFjYl8yLTQtMS0xLTI5MTUz_ee49ded8-838f-4abb-8b02-46f35839c399">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjE3_a25c1ab3-fbe5-4ae5-a23b-2a7c01642dfa">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i03e92b0017504cd9b3490ee50ed3b498_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2.02 Results of Operations and Financial Condition </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF83L2ZyYWc6NjIzYWJiMjVjZjY3NDE4NTg4NTVhOGQ2OGFkMmNkOWYvdGV4dHJlZ2lvbjo2MjNhYmIyNWNmNjc0MTg1ODg1NWE4ZDY4YWQyY2Q5Zl82NQ_a58c757b-7434-4822-9ce8-67313166257f">February&#160;6, 2023</ix:nonNumeric>, Arrowhead Pharmaceuticals, Inc. announced and commented on its financial results for the first quarter ended December 31, 2022. A copy of the press release is furnished herewith as Exhibit 99.1.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i03e92b0017504cd9b3490ee50ed3b498_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01. Financial Statements and Exhibits. </span></div><div style="margin-bottom:12pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d) Exhibits </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="arwr-20230206x8kex9911.htm">Press Release, dated February 6, 2023.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i03e92b0017504cd9b3490ee50ed3b498_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span></div><div style="margin-bottom:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: <ix:nonNumeric contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xMy9mcmFnOmRkYmI0MGNjYWM5MjQwODU5YjEyNzM3NjE1ZTcwMmQ4L3RleHRyZWdpb246ZGRiYjQwY2NhYzkyNDA4NTliMTI3Mzc2MTVlNzAyZDhfMTY0OTI2NzQ0MTkxMQ_a58c757b-7434-4822-9ce8-67313166257f">February&#160;6, 2023</ix:nonNumeric></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.969%"><tr><td style="width:1.0%"></td><td style="width:23.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.369%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ARROWHEAD PHARMACEUTICALS, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Kenneth Myszkowski</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Kenneth Myszkowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>arwr-20230206x8kex9911.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibb314629f06441f1890a70e039be8e20_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">EXHIBIT 99.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font></div><div style="text-align:center"><img alt="ghvnqo5ppwcq000001a.jpg" src="ghvnqo5ppwcq000001a.jpg" style="height:67px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Press Release</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">February&#160;6, 2023</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results </font></div><div style="margin-top:3pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Conference Call and Webcast Today, February 6, 2023 at 4&#58;30 p.m. ET</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">PASADENA, Calif., February&#160;6, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> &#8212; Arrowhead Pharmaceuticals, Inc. (NASDAQ&#58; ARWR) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">today announced financial results for its fiscal first quarter ended December&#160;31, 2022. The company is hosting a conference call today, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">February&#160;6, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">, at 4&#58;30 p.m. ET to discuss the results.</font></div><div id="ibb314629f06441f1890a70e039be8e20_4"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conference Call and Webcast Details</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Investors may access a live audio webcast on the Company's website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;text-decoration:underline">http&#58;&#47;&#47;ir.arrowheadpharma.com&#47;events.cfm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">. A replay of the webcast will be available approximately two hours after the conclusion of the call.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">For analysts that wish to participate in the conference call, please register at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;text-decoration:underline">https&#58;&#47;&#47;register.vevent.com&#47;register&#47;BI9b2661110f7a4b0ebc648bf42d2a403f</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">. Once registered, you will receive the dial-in number and a personalized PIN code that will be required to access the call.</font></div><div id="ibb314629f06441f1890a70e039be8e20_7"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selected Recent Events</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Announced topline results with Takeda from the Phase 2 SEQUOIA clinical study of investigational fazirsiran for the treatment of liver disease associated with alpha-1 antitrypsin deficiency and provided an outline of a Phase 3 study that was co-developed by Takeda and Arrowhead and will be conducted by Takeda. Key results from SEQUOIA included the following&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Fibrosis regression observed in 50% of patients receiving fazirsiran</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Median reductions of 94% of Z-AAT accumulation in the liver and mean reduction of 68% in histologic globule burden</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Treatment emergent adverse events were generally well balanced between fazirsiran and placebo groups</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Results consistent with AROAAT-2002 open-label study previously published in The New England Journal of Medicine</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Earned a $25 million milestone payment from Amgen after the first subject was enrolled in Amgen&#8217;s Phase 3 trial of olpasiran for the treatment of cardiovascular disease</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Earned a $15 million milestone payment from Horizon Therapeutics after the first subject was enrolled in Horizon&#8217;s Phase 1 study of HZN-457, formerly called ARO-XDH, for the treatment of gout</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Initiated dosing in AROMMP7-1001 (NCT05537025), a Phase 1&#47;2a single ascending dose and multiple ascending dose clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARO-MMP7, an investigational RNAi therapeutic designed to reduce expression of matrix metalloproteinase 7 (MMP7) as a potential treatment for idiopathic pulmonary fibrosis (IPF), in up to 56 healthy volunteers and in up to 21 patients with IPF</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Presented interim data on the cardiometabolic pipeline in three late-breaking oral presentations at the American Heart Association (AHA) Scientific Sessions 2022 and at a virtual analyst and investor event. Key results included the following&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">ARO-APOC3, an investigational RNAi therapeutic targeting apolipoprotein C-III (APOC3) being developed as a treatment for patients with cardiovascular disease, severe hypertriglyceridemia (SHTG), and familial chylomicronemia syndrome (FCS), decreased triglycerides by 86%, and non-HDL-C by 45% while increasing HDL-C by 99% in patients with severe hypertriglyceridemia</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">ARO-ANG3, an investigational RNAi therapeutic designed to silence the hepatic expression of angiopoietin-like protein 3 (ANGPTL3) being developed as a treatment for patients with heterozygous and homozygous familial hypercholesterolemia (HeFH and HoFH), decreased triglycerides by 59%, LDL-C by 32%, and was associated with a relative reduction in liver fat fraction in patients with mixed dyslipidemia</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Olpasiran, which was originally developed by Arrowhead using its proprietary Targeted RNAi Molecule (TRiM&#8482;) platform and licensed to Amgen in 2016 and is designed to lower levels of lipoprotein(a) (Lp(a)), a genetically-determined independent risk factor for cardiovascular disease, reduced Lp(a) levels by more than 95% in patients with established atherosclerotic cardiovascular disease. These data were simultaneously published in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%">New England Journal of Medicine</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> (NEJM)</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Strengthened the balance sheet with the sale of Arrowhead&#8217;s royalty interest in olpasiran to Royalty Pharma for&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">$250 million in cash upfront</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Up to $160 million in additional payments contingent on the achievement of certain clinical, regulatory, and sales milestones</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.46pt">Retained rights to $400 million in development, regulatory, and sales milestone payments potentially due from Amgen from the 2016 out-licensing agreement</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ibb314629f06441f1890a70e039be8e20_10"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Selected Fiscal 2022 Financial Results</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ARROWHEAD PHARMACEUTICALS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CONSOLIDATED CONDENSED FINANCIAL INFORMATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(in thousands, except per share amounts)</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:70.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Year Ended December 31,</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">OPERATING SUMMARY</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">62,546</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">27,439</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating Expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.72pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">83,695&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">65,765&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.72pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">General and administrative expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">20,985&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">24,995&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">104,680&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">90,760&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating loss</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(42,134)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(63,321)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">340&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">449&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Loss before income tax expense and noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(41,794)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(62,872)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">17&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss including noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(41,811)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(62,872)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss attributable to noncontrolling interest, net of tax</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(486)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss attributable to Arrowhead Pharmaceuticals, Inc.</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(41,325)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(62,872)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss per share attributable to Arrowhead Pharmaceuticals, Inc. - Diluted</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(0.39)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(0.60)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-average shares used in calculating - Diluted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">106,039</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">104,534</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">FINANCIAL POSITION SUMMARY</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br>2022</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br>2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash, cash equivalents and restricted cash</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">202,249&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,005&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Short-term investments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">299,582&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268,391&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term investments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">115,774&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,872&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total cash resources (cash and investments)</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">617,605</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">482,268</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">273,884&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">209,671&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">891,489</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">691,939</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current deferred revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">66,281&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,099&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term deferred revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">40,789&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,950&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">388,047&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">143,551&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Liabilities</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">495,117</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">273,600</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Arrowhead Pharmaceuticals, Inc. Stockholders' Equity</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">377,039</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">398,520</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Noncontrolling Interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19,333&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,819&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Noncontrolling Interest and Stockholders' Equity</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377,039</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">418,339</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Liabilities, Noncontrolling Interest and Stockholders' Equity</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">872,156</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">691,939</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares Outstanding</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106,140</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">105,960</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font></div><div id="ibb314629f06441f1890a70e039be8e20_13"></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">About Arrowhead Pharmaceuticals</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead&#8217;s RNAi-based therapeutics leverage this natural pathway of gene silencing.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">For more information, please visit www.arrowheadpharma.com, or follow us on Twitter &#64;ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http&#58;&#47;&#47;ir.arrowheadpharma.com&#47;email-alerts.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Safe Harbor Statement under the Private Securities Litigation Reform Act&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">This news release contains forward-looking statements within the meaning of the &#34;safe harbor&#34; provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this release except for historical information may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;hope,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; or &#8220;continue&#8221; are intended to identify such forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our business, expectations for our product pipeline or product candidates, including anticipated regulatory submissions and clinical program results, prospects or benefits of our collaborations with other companies, or other characterizations of future events or circumstances are forward-looking statements. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of numerous factors and uncertainties, including the impact of the ongoing COVID-19 pandemic on our business, the safety and efficacy of our product candidates, decisions of regulatory authorities and the timing thereof, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, the enforcement of our intellectual property rights, and the other risks and uncertainties described in our most recent Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and other documents filed with the Securities and Exchange Commission from time to time. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contacts&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Arrowhead Pharmaceuticals, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vince Anzalone, CFA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">626-304-3400</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">ir&#64;arrowheadpharma.com</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Investors&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">LifeSci Advisors, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Brian Ritchie</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">212-915-2578</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">britchie&#64;lifesciadvisors.com</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">www.lifesciadvisors.com</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Media&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">LifeSci Communications, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Josephine Belluardo, Ph.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">646-751-4361</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">jo&#64;lifescicomms.com</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">www.lifescicommunications.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Source&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Arrowhead Pharmaceuticals, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"># # #</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>arwr-20230206.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:f39ea126-5149-4ac1-b527-7ebd56cbc4f4,g:c164d589-8486-4fb3-8040-3ae80947f032-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:arwr="http://www.arrowheadresearch.com/20230206" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.arrowheadresearch.com/20230206">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="arwr-20230206_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="arwr-20230206_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.arrowheadresearch.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>arwr-20230206_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:f39ea126-5149-4ac1-b527-7ebd56cbc4f4,g:c164d589-8486-4fb3-8040-3ae80947f032-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_47a358eb-72af-4732-be0c-c57929ae2245_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_bf1443db-5965-4a2b-8811-b8c6c62f734b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d171d7fd-0bcd-43a9-bdad-9a3ac9332610_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_dfb757c4-cf93-4693-903d-8a660b905fd8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_03f3c466-0d68-4c84-b210-328c630fc3eb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_6c776538-37f7-4960-bbbf-d95e4c8dfa9e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_739a3983-5945-4b43-8acb-3a94fefa626c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c35a3fbc-1713-4cd1-8211-8336ed2b54aa_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7fd38531-4954-4ba5-a648-80a1870cd9f7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2c61c090-504b-4d6f-a9c5-eca092963c57_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_28607ea6-ee52-41d5-a53e-f180c054c79e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_03098fdc-3fdb-4886-a98c-8d3357b0a5e8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_66e0a46f-094c-4898-aabc-9dd9d87912e7_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cd745d6e-facf-462d-9e37-82ba7c9e951a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d1e063c1-9b90-4735-93cf-f56d7079331e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_695fc3d6-f8cf-43ef-8272-e0fe194fb745_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_05f2956f-f989-4d78-a293-f32eab959591_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d4d9609b-6f62-4340-9f61-bc3a7d3f8122_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_999e47a3-ecb1-4e6d-aac7-ff42905f9084_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_271f6f9d-2427-4ad9-8565-391067485db0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_27165e4f-0b4f-43a1-8387-8be68ff3ed8b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7a76f809-ec1c-4af5-bda7-3b367f24f2d3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_50771941-d7b9-4fae-a8fb-581bf3996240_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>arwr-20230206_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:f39ea126-5149-4ac1-b527-7ebd56cbc4f4,g:c164d589-8486-4fb3-8040-3ae80947f032-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.arrowheadresearch.com/role/Cover" xlink:type="simple" xlink:href="arwr-20230206.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.arrowheadresearch.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f0628d24-6104-4806-8dcf-d9b0d233576a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_DocumentType_f0628d24-6104-4806-8dcf-d9b0d233576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5be2f052-2fe6-4526-bf49-adf7af3941f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_DocumentPeriodEndDate_5be2f052-2fe6-4526-bf49-adf7af3941f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c578fe50-370c-4f11-8528-2278e2f34b40" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityRegistrantName_c578fe50-370c-4f11-8528-2278e2f34b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_73ba52c7-9c40-46b2-9f55-5e5d2126abd4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_73ba52c7-9c40-46b2-9f55-5e5d2126abd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_519e8627-e664-4be8-a902-2c7214f3ce23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityFileNumber_519e8627-e664-4be8-a902-2c7214f3ce23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a39c518e-43fb-4ebe-bf91-b16d09a06542" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityTaxIdentificationNumber_a39c518e-43fb-4ebe-bf91-b16d09a06542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_19c8bffa-6a09-4cf2-9a4c-6e92d1a1556b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityAddressAddressLine1_19c8bffa-6a09-4cf2-9a4c-6e92d1a1556b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_06dd7f0e-95a8-4cf4-ad55-24e3bb026ff0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityAddressAddressLine2_06dd7f0e-95a8-4cf4-ad55-24e3bb026ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_119e4d84-5e90-4e23-ae84-60b8ef901c66" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityAddressCityOrTown_119e4d84-5e90-4e23-ae84-60b8ef901c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_63fd021b-b176-4dea-b71d-33cfabcf7098" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityAddressStateOrProvince_63fd021b-b176-4dea-b71d-33cfabcf7098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a5fa160a-8fe2-4e51-9f8a-6ee214eb0a86" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityAddressPostalZipCode_a5fa160a-8fe2-4e51-9f8a-6ee214eb0a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b76fe29b-c6c6-488f-b7da-9e4e64b48965" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_CityAreaCode_b76fe29b-c6c6-488f-b7da-9e4e64b48965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bd85f8b1-f455-4b46-9536-573175c1f630" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_LocalPhoneNumber_bd85f8b1-f455-4b46-9536-573175c1f630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_f6be2a85-ac74-4752-b646-069bf894ca9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_WrittenCommunications_f6be2a85-ac74-4752-b646-069bf894ca9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_babeecb6-ce8f-4ec3-92ab-894c6971a687" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_SolicitingMaterial_babeecb6-ce8f-4ec3-92ab-894c6971a687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e9b0dff8-182c-4d07-af89-9bd69e0a4505" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_PreCommencementTenderOffer_e9b0dff8-182c-4d07-af89-9bd69e0a4505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_291c2c80-abd0-4a53-a030-176aa4bfdcb6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_291c2c80-abd0-4a53-a030-176aa4bfdcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b3365064-040d-46e2-8f2f-37e4ad6435ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_Security12bTitle_b3365064-040d-46e2-8f2f-37e4ad6435ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b2209fb4-bb04-4cae-94fe-25c97b6adbd5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_TradingSymbol_b2209fb4-bb04-4cae-94fe-25c97b6adbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5c462b48-9fa5-417a-b786-c3fddce049c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_SecurityExchangeName_5c462b48-9fa5-417a-b786-c3fddce049c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e8769585-6cb7-4d1b-b639-1ecb682a12a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityEmergingGrowthCompany_e8769585-6cb7-4d1b-b639-1ecb682a12a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fd845f68-eb85-44fb-8a38-4fac654fc4a6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_EntityCentralIndexKey_fd845f68-eb85-44fb-8a38-4fac654fc4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e4b4bdc1-e848-48db-8339-0c1e11727ca2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fbfc37c4-5884-4ab3-b26d-cddd94a9dc8a" xlink:to="loc_dei_AmendmentFlag_e4b4bdc1-e848-48db-8339-0c1e11727ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ghvnqo5ppwcq000001a.jpg
<TEXT>
begin 644 ghvnqo5ppwcq000001a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )8!P@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC8_KC%9TOQ+TE>(K6\<^I55'\Z\LHKHCEU%;W9B\94>QZ2WQ/M@?DTR4CWE
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1534W:/2;QT8JRP.58'!!VGFO'/[=
MUC_H*WW_ ($/_C2;L-*Y[=17B/\ ;NL?]!6^_P# A_\ &O9[)F:QMV8DL8E)
M)/)XH3N#5B>BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KFO$OC&TT)6@BVW%\1Q&#PGNW^'7Z
M5E>+?&XLS)I^E.&N!Q)..1'[+ZGW[?7IYH[M(Y=V+,QR6)R2:]+"X'G]^IMV
M.+$8KE]V&Y:U'4[S5KMKF]F:60],]%'H!V%4Z**]E))61YK;;NPHHHIB"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O5OAL\K^'9M\K,J
M7+(BDY"C:IX_$UY37JWPV4KX;F)_BNF(_P"^5']*X<P_@_,ZL'_%.QKPWQ-_
MR,^I_P#7P_\ .O<J\*\0$MXDU0DY_P!+E'_CQKDRSXY>AT8[X49M%%%>R>:%
M%%% !1110 4444 %=;\.E#>*,_W8'(_0?UKDJ[/X:)GQ#<-CA;5N?0[E_P#K
MUSXIVHR]#;#_ ,6)ZI1117S9[04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!X+/_Q\2?[Y_G4=23_\?$G^^?YU'69H>S>%
MO^17T_\ ZY#^=;%8_A;_ )%?3_\ KD/YUL5H9A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 4]6_Y U]_P!>\G_H)KPVO<M6_P"0-??]>\G_ *":\-J9%1"O
M=K'_ )!]M_UR7^0KPFO=K'_D'VW_ %R7^0HB$BQ1115$A1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /!9_
M^/B3_?/\ZCJ2?_CXD_WS_.HZS-#V;PM_R*^G_P#7(?SK8K'\+?\ (KZ?_P!<
MA_.MBM#,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO7&W\E'^->85ZW\.XO+\+!L?ZR=V_D/Z5PY@[4?F=6#5ZIUE%%%>">L%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >"S_\
M?$G^^?YU'4D__'Q)_OG^=1UF:'LWA;_D5]/_ .N0_G6Q6/X6_P"17T__ *Y#
M^=;%:&84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8="IP170Z7XUU?3F59)OM<(ZI-R?P;K_ #HN'*>MT5C:'XEL-=CQ"QCN ,M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\
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MHHHJB3 \;?\ (H7W_;/_ -&+7D%>O^-O^10OO^V?_HQ:\@J64BYI/_(9L?\
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M[5T.UNB<N4VR?[PX/^/XUIU9 4444 %%%% !7DOC?4OM_B*2-6S%:CRE^O\
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M)&.5'^TO;]17/4AGIOA/QA_:16PU!@MWC$<O02^W^]_.N1\;?\C???\ ;/\
M]%K6"K,CJZ,593D$'!!JSJ-_-J=\]W/CS75 Q'<JH7/XXS1<+:E6O1_AM_R#
M[[_KJO\ *O.*]'^&W_(/OO\ KJO\J%N#V.WHHHJR IKND4;22,%11EF8X 'K
M3J\S\:^)S?3OIEF_^BQMB5U/^L8=OH/UI-C2N/\ $WCB6Z9[/2G:.WZ-..&?
MZ>@_6N*ZG)HHJ2@HKH]$\&:CJZK-(!:VS<B20<L/9>_XXKN+#P1HMD 7@:ZD
M'\4QR/R'%%@N>245[O!9VML (+:&(#H(XPO\JF(### $'L:?*+F/ J*]NNM#
MTJ]!%QI]NY/\6P!OS'-<QJGP[M90SZ;.T#]HY3N0_CU'ZT6"YYQ6CH^MWNB7
M0FM9/E)^>)ONN/<?UJ/4M)OM(N/)O8&C)^ZW56^A[U2I#/8(M:MM<\,7MS;G
M:PMY!)&3RAVGC_Z]>/U=TW5)],EE:(Y2:)HI$SPP(Q^G6J5#8)6"O=K'_D'V
MW_7)?Y"O":]VL?\ D'VW_7)?Y"G$4BQ1115$A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 8OBR__L[PS>S*V)&3RTQURW'Z
M9)_"O$J])^)UYMM+&R!^^[2L/H,#^9_*O-J]W+H<M'F[GE8R5ZENP4445WG(
M%%%% !1110 4444 %%%6M.L)M3U""RMQF29MH]!ZD^P'-)M)78TFW9&UX1\,
MOK]]YDP9;&$_O6'&X_W1_7V_"O8(HHX(DBB14C0;551@ #L*K:7IL&DZ=#96
MZX2-<9[L>Y/N:N5\[BL0ZT[]%L>Q0HJE'S"BBBN8W"BBL?5O$VEZ/E+B??,/
M^6,7S-^/8?C2<E%79,I1BKR9L45YS>?$:[=B+*RBC7LTI+'],8_6LM_'&ON>
M+M$_W84_J#6#Q5-'-+&TEMJ>M45Y3#X\UR(@O+#+CL\0&?RQ6YI_Q&B8A-0L
MS'ZR0G(_(_XTXXFFQQQE*76QW5%5+#4K/4X/.L[A)D[[>H^HZBK=;)IZHZ4T
MU=!1113&9>NZ';:]IS6LXPXYBD Y1O7Z>HKQ;4+"XTN_EL[I-LL9P?0^A'L:
M]]KDO'7AX:KIAO8$_P!+M5)X'+IU(_#J/Q]:[\#B73ER2V9R8JASKF6Z/):*
M**]T\H]"^&%M\^HW1'0)&I_,G^E>BUR?P[M?(\+B4CFXF=_P&%_]E-=6S!5+
M,< #)-?.8R7-7D>SAX\M)'C/C6Y^T^+;T@Y6,K&/P4 _KFN?JQ>W!O+^XN6Z
MS2M(?Q.:KU[]./)!1[(\B<N:384445H2%%%% !1110 4444 =?\ #FW\WQ(\
MI'$,#-GW) _D37K%>?\ PPML0:A=D?>9(U/T!)_F*] KY_'RYJ[\CU\)&U)!
M1117&=(4444 %%%% !1110 4444 %%%% &%XLUK^Q=&=XVQ<S?NX?8]V_ ?K
MBO'R2223DGJ:Z;QUJ1OO$#P*V8K4>6.>-W5C^?'X5S%0RT%=WX0\'K,D>I:G
M'F,_-# W\7^TWMZ"L;P?H8UG5MTRYM;?#R?[1[+^/\@:];  & , 4TA-@  ,
M 8 I:**HD**** "BBB@"&ZM8+VW>WN8EEB<896'%>5^*?"LFAS>?!NDL7.%8
M]4/H?Z&O6JBN;:*\MI+>= \4B[64]Q2:N-.QX-16CKFDR:+JLMG(257YHW/\
M2GH?\^E9U24%>W:%_P B]IO_ %Z1?^@"O$:]NT+_ )%[3?\ KTB_] %.(I&A
M1115$F!XV_Y%"^_[9_\ HQ:\@KU_QM_R*%]_VS_]&+7D%2RD/BD>&5)8SAT8
M,I]"*916UX5TD:OKT,+KF"/][+[J.WXG _&D4=MX)\.+IUDNH7,?^ESKE 1_
MJT/]3_\ 6]:ZZBBK,PHHHH **** "O+/B%_R,B_]>Z_S:O4Z\L^(7_(R+_U[
MK_-J3''<Y2I%G=;:2 ']V[J[#W4$#_T(U'14EES2M-FU;4H;* ?-(>6[*.Y-
M>SZ;IUOI5C':6R!8T'7NQ[D^]<M\/=*$&G2:E(O[RX.V,^B _P!3_(5VE4D0
MV%%%%,04444 %>3>--<.JZNT$3YM;8E$QT9N[?T_#WKT#Q1J9TKP_<SHV)6'
MEQ?[S<?H,G\*\:J6RHA5[2=*N=9OTM+9?F;EF/1!W)JD 20 ,D]!7L'A;0ET
M32E5U'VJ8!YF]#V7Z#_&DD-NQ:T70K/0[416R9D(_>2L/F<_X>U:=%%60%%%
M% !1110 5G:QHMGK=H8+J/D?<D'WD/L?Z5HT4 >(ZSH]SHE^UK<C/=''1U]1
M6?7LOB70X]<TIX<#[1&"T#^C>GT/3_\ 57C;HT;LCJ593@@]0:AJQ:=S?\(:
MX='UA5D;%K<$)*">!Z-^'\B:]>KP&O8?"&IG4_#L#NV98?W,A]QT/Y8IH3-V
MO-_B+IOE7\&HHORSKY<A_P!H=/S'\J](K'\3Z;_:N@7,"KF55\R+UW+S^HR/
MQIL2W/&:Z?P)J7V+Q L#MB.Z7RSZ;NJ_X?C7,4^*1X94EC8JZ,&4CL1TJ2CW
MNBJFF7J:EIEO>)C$T88@=CW'X'(JW5D!1110 5S7CC4OL/AV2)6Q+='RE^G\
M7Z<?C72UY9X^U+[9KWV5&S':KL_X$>3_ $'X4F-;G*5/96LE]?06L7WYG"#V
MR:@KLOAYIOVC5I;]Q\ELF%_WVX_EG\ZE%&1XKT==&UIH8E(MY%#Q9].A'Y@U
MB5ZA\0--^U:*EXBYDM6R?]QN#^N/UKR^A@MCO/AQJ6V6ZTUVX8>=&/<<-_3\
MJ]"KP_1]0;2]7M;P9Q&X+ =U/!'Y$U[>K*Z*ZD%6&01W%4B6+1113$%%%% '
M"_$;4MEM;::C?-(?-D'L.!^9S^5>=UK>)-2_M77[JX!S&&V1_P"ZO _/K^-9
M-0RUL:OAO3?[5UZUMF&8]V^3_=')_/I^->TUPOPYTW9;7.I./FD/E1G_ &1R
M?S./RKNJI$L****8CP6?_CXD_P!\_P ZCJ2?_CXD_P!\_P ZCK,T"O4/"'A1
M--@2_O8PUZXRJL/]4/\ XK_]5<KX'TD:EK@FE7,-H!(P/0M_"/Z_A7K%4D2V
M%%%%42%%%% !5/5--@U;3Y;.X7*..#W4]B/<5<HH \)OK.73[Z:TG&)(G*GW
M]_I5>NT^(U@(=3MKU1@7$95O]Y>_Y$?E7%U#+/2?AUJ!FTVXL'.3;ON3_=;M
M^8/YUVM>5> +DP^)1%GB>%DQ]/F_]EKU6J6Q+W"BBL_7-0_LO1;J\_BC3Y/]
MX\#]2*8CSSQUK1U#5C91/FWM3M.#PS]S^'3\ZY2E8EF+,223DD]Z2H++NE:7
M<:QJ$=G;+EFY9CT0=R:]>T70[/0[00VR9<X\R4CYG/O[>U4/!VAKI&D+)(N+
MJY >0D<J.R_A_,UT54D2V%%%%,04444 %%%% '#^,?"2SQR:GI\8691NFB4?
M?'=A[_S^O7SFO?J\E\::*NDZQYL*[;:YRZ #A6_B']?QJ6BDSFZ]?\(ZR=8T
M1#*V;F#]W+GJ?0_B/US7D%=3X"U$V?B 6['$=TI0_P"\.5_J/QI(;/5:***L
M@BN)X[6VDN)FVQQJ78^@%>*ZSJDNL:I->2Y&\X1<_=7L*[[XA:D;;28K%&P]
MT^6Q_<7G^>/R->95+*05N>&O#D^OW>,F.TC/[V7^@]_Y5E6=I+?7L-K ,R2N
M%7\:]KTO38-)TZ&SMQ\L8Y;NQ[D_6A(;=B2RL;;3K5+:TB6*)>BC^9]35BBB
MJ("BBB@ HHHH *X;Q7X+29'O]*BVS#F2!1P_NH]?;O\ S[FB@$SP&BNS\>:
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M+&#] 2?YBN\JEL2]PHHHIB"BBB@ HHHH **** "O*/'6G"Q\0M,@Q'=+YO\
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M_P"%EP_] Q_^_P /\*+H+,[NBN$_X67#_P! Q_\ O\/\*/\ A9</_0,?_O\
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M0?;?]<E_D*\)KW:Q_P"0?;?]<E_D*(A(L44451(4444 %%%% !1110 4444
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M_-(SM]2<UT9;3O-S[&.-G:*CW(:***]H\P**** "BBB@ HHHH *U_#%G]O\
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MF(**** "BBB@ HHHH *Y/XA?\BVO_7PO\FKK*XKXD3A=*L[?/,DY?_OE2/\
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M_P#?D_XT6871PE%=W_PK2;_H)Q_]^3_C1_PK2;_H)Q_]^3_C19A='"45W?\
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M_P A7A->[6/_ "#[;_KDO\A1$)%BBBBJ)"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JMJ'_ "#;K_KB_P#(U9J.X7?;2IC.Y",>
MO%-;B>Q\^4445]6> %%%% !1110 4444 %%%% '?_"_'VK4NF=B?S->D5Y?\
M,Y0NM7<7=[?</P8?XUZA7S^/7[]_(]?"/]T@HHHKC.DXWXC?\@>U_P"OC_V4
MUYK7JOCVV,_AEW SY$J2']5_]FKRJO-Q2_>'CXU6JA1117.<@4444 %%%% !
M1110 5[AI/\ R!K'_KWC_P#017B44;33)$@RSL%4>YKW:&,0PQQ+]U%"C\*[
M,(M6ST< M9,?1117<>D%%%% ')?$'4OL7A[[*K8ENWV?\!'+?T'XUY+73>.M
M5_M+Q%)&C9AM1Y*_4?>/Y\?A7,U]#@J7LZ*ON]3Q\34YZC\@HHHKK.<****
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M1>TW_KTB_P#0!3B*1H44451)@>-O^10OO^V?_HQ:\@KU_P ;?\BA??\ ;/\
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MQ_Y!]M_UR7^0IQ%(L44451(4444 %%%% !1110 4444 %%%% !1110 4444
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M.IS'$?)3Z+P?US6#7KX2G[.BD>=B)\]1L^AZ*CM_^/:+_<'\JDKYP]H****
M"BBB@ HHHH **** "BBB@#F_&>BG5M&,D*YN;;,B =6'\0_K^%>2U[]7E_C3
MPT=.N6U"TC_T.5LNJC_5,?Z'_P"MZ5+129R->C>#O%J3QQZ9J,@691MAE8\.
M.RGW_G]>OG-%),;1[]17E^@^.KK3U6WOU:ZMQP'S^\4?U_'\Z[W3O$&EZJH^
MRWD9<_\ +-CM?\C_ $JDR6C3HHHIB"BCIS6-J7BG2-,4^;=I)(/^64)WM^G
M_'% &S7G_C/Q:DD<FEZ=)N!^6>93P1_=']3^%9.O>-;W5E>WMP;6U;@A3\[C
MW/\ 0?K7+U+92045:T^PGU.]2UMUR[<D]E ZD^U5:105[=H7_(O:;_UZ1?\
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MW!Q_?;=_.LBB@9KR>*=<ESNU.<9_NG;_ "K-GNKBZ??<3RS-_>D<L?UJ*B@
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MR0R##*W>IJ* /)O$OA&XT61KBW#36)/#]3'[-_C7-5[Z0&!! (/!![UR&M>
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MMO\ KDO\A7A->[6/_(/MO^N2_P A1$)%BBBBJ)"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH S/$.G_VIX?O;0#+O&2@_P!H
M<C]0*\+KZ'KQ3Q;IG]E>([J(+B*1O.C_ -UN?T.1^%>KEE35TWZG!CH;3,.B
MBBO7/."BBB@ HHHH **** "BBB@#IO!_B=M"O##<$FPF/S@<[&_O#^O_ -:O
M7TD26-9(V#HPRK*<@CU%?/5=9X3\8RZ*RV=YNEL&/&.6B/J/;U'Y>_FXW!^T
M]^&_YG;AL3R>Y+8];HJ&VNH+RW2XMI5EA<95U.0:FKQ6K:,],**** "BBB@
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M"BBB@ HHHH **** "BBB@ HHHH **** "J%WHFEWQ)N;""1CU;8 WYCFK]%
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M5)THHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU9;18.M36\D=;3)98X(FDFD2.-1EF=L ?C7FM_\ $N]E!6PLXH!_?D.]ORX
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M@TD^$M/).?D/_H1K=KY>M_$EZL]VG\"] HHHK,L**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M("OC/!QVKQ"O6_ O_(J6W^^__H1J4RFCHZ***HD**** "BBB@ HHHH ****
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M*M"_7J>/7HNE*W0;111728!1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWD&Z%SU(]#[C_"IO!NI-IWB*W&[$5P?)<?7H?SQ^M"T&]3U^N0^(W_(O6_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\5ZY-$\4FH.R.I5@47D'KVKTW_A%M#_Z!D'Y&H[CP[X=M;>2>>PMHXHUW,S
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M[C_^@FM#XD?\AFT_Z]__ &8UG^!?^1KMO]Q__034]2^AZW7E7Q =F\3$$\+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC7A->\W,9FM9HE(#.C*,].17FO\ PKG6/^?FQ_[[?_XFDQH[#P3_ ,BA8_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQAL8SM &?TJQ12L.X4444Q!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139736920065184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 06, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  06,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arrowhead Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-0408024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">177 E. Colorado Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Pasadena<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">304-3400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARWR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000879407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>arwr-20230206_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="arwr-20230206.xsd" xlink:type="simple"/>
    <context id="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
        </entity>
        <period>
            <startDate>2023-02-06</startDate>
            <endDate>2023-02-06</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF80L2ZyYWc6NDRhYWFhMGFjNzc2NDA2Y2FjMGUwOGUyODc3NDE5M2QvdGFibGU6N2FlMjAxYjJiNzA3NDAwZmExNmQ0NzQ5NTExZmE1MDkvdGFibGVyYW5nZTo3YWUyMDFiMmI3MDc0MDBmYTE2ZDQ3NDk1MTFmYTUwOV8yLTEtMS0xLTI5MTUz_2c763a82-b951-4517-bde3-a4ff3eff8a58">0000879407</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF80L2ZyYWc6NDRhYWFhMGFjNzc2NDA2Y2FjMGUwOGUyODc3NDE5M2QvdGFibGU6N2FlMjAxYjJiNzA3NDAwZmExNmQ0NzQ5NTExZmE1MDkvdGFibGVyYW5nZTo3YWUyMDFiMmI3MDc0MDBmYTE2ZDQ3NDk1MTFmYTUwOV8zLTEtMS0xLTI5MTUz_626c938e-f6e1-4eeb-8378-5767b43556fa">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjE5_cf211cec-7871-4cf6-88af-e977c38530b2">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xODM_a58c757b-7434-4822-9ce8-67313166257f">2023-02-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjI2_fa7c7de5-e190-4ba8-9012-0092dd22146e">Arrowhead Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODcyZWVmMjlkNmE0NDI5N2FhNjdjMTBiZTZkYzQ1NWMvdGFibGVyYW5nZTo4NzJlZWYyOWQ2YTQ0Mjk3YWE2N2MxMGJlNmRjNDU1Y18wLTAtMS0xLTI5MTUz_47d958f9-bfb0-401c-88da-776e8680f6e7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODcyZWVmMjlkNmE0NDI5N2FhNjdjMTBiZTZkYzQ1NWMvdGFibGVyYW5nZTo4NzJlZWYyOWQ2YTQ0Mjk3YWE2N2MxMGJlNmRjNDU1Y18wLTItMS0xLTI5MTUz_e9ec602c-882f-4789-acf8-5d9e45eee9aa">001-38042</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODcyZWVmMjlkNmE0NDI5N2FhNjdjMTBiZTZkYzQ1NWMvdGFibGVyYW5nZTo4NzJlZWYyOWQ2YTQ0Mjk3YWE2N2MxMGJlNmRjNDU1Y18wLTQtMS0xLTI5MTUz_7206f19b-ddcc-4bbb-8269-043b6c6857f9">46-0408024</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjIw_2b4e8f08-53cb-49ec-91ca-fad19d683a25">177 E. Colorado Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjMy_8d7531c8-fe1c-4d07-b05d-8deaf34da5e9">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjI3_826ff097-00c1-471f-930b-ea4435add41a">Pasadena</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjE4_d053b4bf-4594-4178-b8d0-98e33263a0ab">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8zODE_9ea22be3-8db9-4649-ab3b-e0aae537bbe8">91105</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl80NDY_26144428-d561-4234-8a68-06ead0341076">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjI5_13b28c47-c208-432b-a332-bb08a222e3fc">304-3400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8wLTAtMS0xLTI5MTUz_3e583bc0-1d50-429d-bd1f-1e855354dc8b">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8xLTAtMS0xLTI5MTUz_f13e819d-72a5-4ac3-9cdf-3f30f3ea9cd0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8yLTAtMS0xLTI5MTUz_136ea854-579a-4ed3-903d-f8828db2a942">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6ODc5YzNkMGM5MGZmNDFhZGE2OWMwNzllOWYxYTg5ZDIvdGFibGVyYW5nZTo4NzljM2QwYzkwZmY0MWFkYTY5YzA3OWU5ZjFhODlkMl8zLTAtMS0xLTI5MTUz_36a27d15-6283-4e03-9e6b-57628adfce80">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6YmRjYWFhMzg4MDFhNDU5ZTk1NzI1YTdiYWJjNTJhY2IvdGFibGVyYW5nZTpiZGNhYWEzODgwMWE0NTllOTU3MjVhN2JhYmM1MmFjYl8yLTAtMS0xLTI5MTUz_44a93c3d-165f-458b-9b90-76e16ede6727">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6YmRjYWFhMzg4MDFhNDU5ZTk1NzI1YTdiYWJjNTJhY2IvdGFibGVyYW5nZTpiZGNhYWEzODgwMWE0NTllOTU3MjVhN2JhYmM1MmFjYl8yLTItMS0xLTI5MTUz_fd752f2d-3edc-490a-8d30-66a26f225481">ARWR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGFibGU6YmRjYWFhMzg4MDFhNDU5ZTk1NzI1YTdiYWJjNTJhY2IvdGFibGVyYW5nZTpiZGNhYWEzODgwMWE0NTllOTU3MjVhN2JhYmM1MmFjYl8yLTQtMS0xLTI5MTUz_ee49ded8-838f-4abb-8b02-46f35839c399">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xL2ZyYWc6NGU1YjNjNzY4OThjNGVkY2IwY2JiNjk3ZGI0MDE0MjYvdGV4dHJlZ2lvbjo0ZTViM2M3Njg5OGM0ZWRjYjBjYmI2OTdkYjQwMTQyNl8xMjE3_a25c1ab3-fbe5-4ae5-a23b-2a7c01642dfa">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentPeriodEndDate
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF83L2ZyYWc6NjIzYWJiMjVjZjY3NDE4NTg4NTVhOGQ2OGFkMmNkOWYvdGV4dHJlZ2lvbjo2MjNhYmIyNWNmNjc0MTg1ODg1NWE4ZDY4YWQyY2Q5Zl82NQ_a58c757b-7434-4822-9ce8-67313166257f">2023-02-06</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i16c74cfbef0042afa87140adac0f831d_D20230206-20230206"
      id="id3VybDovL2RvY3MudjEvZG9jOjAzZTkyYjAwMTc1MDRjZDliMzQ5MGVlNTBlZDNiNDk4L3NlYzowM2U5MmIwMDE3NTA0Y2Q5YjM0OTBlZTUwZWQzYjQ5OF8xMy9mcmFnOmRkYmI0MGNjYWM5MjQwODU5YjEyNzM3NjE1ZTcwMmQ4L3RleHRyZWdpb246ZGRiYjQwY2NhYzkyNDA4NTliMTI3Mzc2MTVlNzAyZDhfMTY0OTI2NzQ0MTkxMQ_a58c757b-7434-4822-9ce8-67313166257f">2023-02-06</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%!+ 0(4 Q0    ( %R 1E80GZ$=[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %R 1E:97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ 7(!&5JX_CK!C!   *A$  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %R 1E:?H!OPL0(  .(,
M   -              "  :8,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M7(!&5I>*NQS     $P(   L              ( !@@\  %]R96QS+RYR96QS
M4$L! A0#%     @ 7(!&5JK$(A8S 0  (@(   \              ( !:Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %R 1E8D'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( %R 1E9ED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="arwr-20230206.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arrowheadresearch.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="arwr-20230206.htm">arwr-20230206.htm</File>
    <File>arwr-20230206.xsd</File>
    <File>arwr-20230206_lab.xml</File>
    <File>arwr-20230206_pre.xml</File>
    <File>arwr-20230206x8kex9911.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "arwr-20230206.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "arwr-20230206.htm"
     ]
    },
    "labelLink": {
     "local": [
      "arwr-20230206_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "arwr-20230206_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "arwr-20230206.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "arwr",
   "nsuri": "http://www.arrowheadresearch.com/20230206",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arwr-20230206.htm",
      "contextRef": "i16c74cfbef0042afa87140adac0f831d_D20230206-20230206",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.arrowheadresearch.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arwr-20230206.htm",
      "contextRef": "i16c74cfbef0042afa87140adac0f831d_D20230206-20230206",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arrowheadresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-002417-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-002417-xbrl.zip
M4$L#!!0    ( %R 1E8"SZHTMQ4  #.6   1    87)W<BTR,#(S,#(P-BYH
M=&WM7>MWVKBV_W[^"EWFWG/:M2*PY3=M<Q8-)&4F-@TA9>!+EFS)P6 P8YL
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MGYJ&K$J444_R345FI]4E*9<T%="(#D77/"C71D#?? ^&$].P/F)\]A>?%U#
MH&FF?)N[U>C\D#3/.XH]8?W:>?? ZC?ZE8MN:S#O]"M3N^7)=K79[U;#P+XX
MTNR#;Z'3^AQVJT[@5 ?JH>*$G8MH:I,3S1[6IW:UICBMBM0A1UJG;TL-4;9U
M,NVVCRXZ_2.ML6]*AZ0[[[0]W:DV>YWV?L\^V.\[%QYQJA72(?M]^^!DVC@X
MF3>JGN)4:YI-CL[9P7[@'ISH#MD/[7YEUNG_&3@7%7A>F7:'M9DS/)(<H,]I
MU6;P'6@>+.I\@[ZT4;<5*9WVR=RN[@= IV)7/<FN?AYV6C72K1Y!.P/9;NW#
M=^C[FSD_;-52^UB:';;JFMTZN3@EGJ$KU"38M309JYIL8)=Q!5/5]Q7N^R;5
MS,*N!/],PU(EXV/IQJ*^Y!I7 '*9@-W]D)X54"X[T.PL+?O!C#/LTU!@SMNB
M/[SH%W<672>Z9RDFQ[[.8=$Y=[&I&";6#-UP5473=)\6=O<KA\>U.^M=NBG?
M,?=YS &6DA6P)/"[G&0J!3@"97A>3@&,/A628#@.!99EO_5BP3 W$*@X2Q@T
M4;K91M[_5:<+&I)H$F??,A M+[@PYXRG<.&R(9[!S/);P,1W/^ QR@CB*Y71
M7OVOFP)SN_+N\J>;K8]A?B.V_ 98'Z=5,#9V!5%"4PA0OOWLDDQV3]'ED^7W
M92>E&Q.UG-7+:2Q=P_,2H'X._=ET?L_>.)4+U^LLU,4P&.$>%S916=7&Z8=I
MP-)>69:D_RMDY78_)F,*'.7&):B=?\X;N=.4(!C3,#@;E3V801Y#"REU0[XL
MX$8Q$(Z]* SI..'EY8</2YV5:V6<5?HPI/$9$.=&:1H-RX(V, /3P*/AHI.L
MO_SQ%=E%*2<]A0E*V;+GQ>-B]JB4LKO/++-H2?<_EHKRY;-2UG:\++"<O7%:
MR.K!J,0T?2HHA5L#3Z,Q-&3 4% 2A0%#?TC9OP]CRE@P.BM+2,Y:N>JFE,W%
MFI,MNET^!RJBN+SLP =V E0>!N&\_)]6, 10</@4-:,A'?UG)P$#"$RX./#S
M@DEPP<NRF/'LZS0?H 'M9,NS&+ L:S E)TZ]5:NBXU:E53M&-SED"\D]KNV=
M-.NM.M!:<:JH]O?>EXIS4$-[#=NN'Q_7&\XFQT#6&D.[<ORE[ART&LX.JA;W
MBN#,:*IU/]TW!0DX[,/F)960HFF8VRJHBY$\EZPNYD>(OW+/[&]"%O8;31N]
MH)FX=,YS)V>3QN#LTA@\.)$[?0<,P8[::/7ZSL&W08?4IQT"AEY_H'0/ZF"P
MU22[WP'#[IO*OOP9=DEX[O8CJ=OZ%MC$5IS^F=8XL*5NN]GO]#_W.\,Z:;38
M /H"VH_F3FC.['Y-._5\(LL>][ !\X9A(G5LFM3'W#(,3S$U17))8=?$?]TU
MY=XD>>LE.0/K;5$)H-2:-:>%FK6OC69K^U78UY/F\4D%"&XU$*CDEM"[LH(:
M321K[ZKO46-_ZX?0^E)#UZR)2TNBLM<"\I%L*>HVK8.Z<A _ ?V_9HY-+7=W
M;@8+&/R"A]!G3U3#C,[QG-,8\]%OIBX:5?N4:J9G:(:+#551L6H2@BV/FU@W
M%%F1=9UHA@\ZF[OQA,9SI.]D,>RU5<>V<-RE3&Q"9@4+HLA'33Z.XG23XBFM
M1>^[)<$@%6' DQ3Q<[';$6?T<_;^S5+85DMA6XS\%P_U-_E9D(@]E-2!)[\9
M<-O].CGUJ>$9C&N8RY:$59>:V))D@B7)(HP1(JLZ+^Q6XCB:BM =^MJCH ,]
M/LG$)=E!]9%7W"(@OXU-JX'\76U&O31C!X%0\24;()J@9,P]$5)E*!BA($V0
M!V,&6M^_12FV#K$VPSZ/4[X_=]DMJZA;^E.679&+!M'76O;'/=,TZTDU?REB
ME4<)U'W2LQ0-,IZAE3!SFT%RWM@ S*H_0W^#\HEB,">S[(?C% S.O6@R2N/Y
M7L1N^FLBRT-L<:5\'$?GHIU7ZJCEF[R-JC?OMK\-[7XX<(8UR:G6-8?L]YP^
MZ]NMST&WU1UT+HYDIVW?WN15G0NP%]J=>:-]1#JM(VAWH'3:->(0>V8?_!DZ
MPV;?J0)-LCD];%5N;O*J!K,TT[>PZ[M@+TBRATV346P8.C=U4_)U;H"OPD,Z
MI3&_US!8B,$#''X#_-^$80UAV ]"#JV[H'3>&/O[C%V_R=C<XIXN$<'.Q,>J
M85J8>KZ)-69Q5>.<6Y2*'7@9*R:LT1MG_T3.;M%9?9'HX&50_\;F:[/YT4TV
M-V""?=ER,6.>!_Z>ZV*3Z!:65,75/=W4#-\J[*HZ_""9$E$?Y/.G&RLA]^_:
MLM&X\'.]17,]9S$S+% 4HRCM\1CU)W&0L, 3C+@Y3W<]VL&Y#:[;2+>";B^.
M5J]JG?>BX3!(DE>PK$+5HQP$WU;T@16M-X]1;3@.HSF/MWU-;VHXY$3%54N[
MZ<#M(S=*MC8"^.(V2X6QF"?)XL\A$""_2GOEA^++TU/BJMST);"C%<_%*AC9
MV)(]"HO*9(OIID*)5MB5#0/5BFA/+#YE$?H<GK/;EL?.2Z;[W+=FY+=;,WM^
M:C)#4V3/Q#X']UYEDH%=26/89)SZBLJHQL%&/)X$8!49DK2YA=J#CXVX%4U?
M9RCGAT1+.06[W?<ER\"2Y,G@L<H^MA3)Q9RJJJ*!!E=E\%B_TH2"9J&;6Z7,
M?&[$7^/H/,A.&OUF2U533YFD*:[J^EC5+!6KLF%BUV02MDRN*$17J$3=PNY>
MY?8B_;0U^AHE*0V[P3@/G/Y.*W31J-9.+4X)<;D"&.=:6-55"U-7 5F2*.6:
M8K@N-PN[EBQ+VO9L=MZV*^_)PU@LL=CH',<@@<&8AHC/N#=)@W.Q_PDV)T]V
MA*,83H39CX /D&"$^U,TML6,>_>" B*T2R7F]/<3"<FI=DZ)+JNJ2DS,-!W4
M"U%4;%+=Q)+.*9,4598,O;"K$_VV0+Q_2=0ZC,#M_-J+1J\YU/U#BE\[E167
MF)YJ8(^ 8:TJQ,44U AV7<D$&"-<\;W"KB*I6%'OFF=;CU=723G__L,DLO$A
M02D/^5@L.AIEJWX=K"B(*+#8-;3:@//^EAJR=:DAJ]+>I:S2)A357H][ Y3V
M.*+C<1R!(A8Q93>:(9>'T10%?O9P/XJ'R,1_(3\(!7,'"7!ZRD>,,Y1&* F&
MDS"E(QY-DG".$IH&B3_/:BXJ1"ZL>1Y!BO(FKR4W3:"=&-'1?/G,!\Z*IJ*>
MV!4/1.@S*=_EY5=T%%(MJIKV[ D<EE)4U/6:?=X]D<?NZU6 K\*MW<UKQT$*
MS"SB[)/1(M"9W$W3<*,H="EP9@KR\2H5_.4FG]:Y< ;V@0VT=(=.=;_7/:B1
M1MN>.A=AV&AW9IW6F=:MUE=L\H5]FQQ-.Q>#:7?8D>SV_J#3ZD![%:71/M&Z
M_?U>HQH.['!%DH;"-5-Q/0G+3)/ =+,8=IGL8YF;FJ9H*O-,<#?__8=EJ.J'
M']C)7C Q$G^)MH*;L^_!2$2VRYBH=V5_H_O6"W:$$5[G1S2>Q,E$P"4 ;G,"
ML*<2;0&= C./P7&"B@'04?%2]$XVT-Y^$P&W%Z'@M231-S1X& V.0;-[,)&C
M,QMTH2#U#0I^$ IF=Z# EQ5NR@  !J&:N!9*P9;'?*SXBN0KG,(7Z0T*=J]X
M$0T7S'@7!V258IE<@X+:S.O1T1F_"00JF -9R3<L6!L+OL9<6 7B]I7LU+6P
M>..&[PL'_PT3?@@3YG<P059T3DU-Q9IA4:QR!I@@*0S[IDE,YA)JJ>0-$W:!
M)[%WC2F_:R?(*L/DG?M^/83(R[YAQ%,QHIXD$QZ_(<7S(<7%74="I\1@LH9U
M8BJ %!(@!===<:47,2GS/6Z^60]/00J%8Q6]\]:#"E$8RKZ_BQ2;2P12MST/
MZ"4(?#51,,4J2MI33T ]?#K*>/;@FFP4)?.U$)O-K/KT2*"L/3W)/T^S_,E;
M,IEW=!7RR*/)/.;L!JI!B2SF+&?VSR*Z#$!6?JIU0XJ*N=5STA(WV>;7&W@]
MY(4T21ZO\+9X?/_^0]:E#X\<$BD:JU?MAOZ6BN8*_-O80L8TVT<\G@_=*'R7
MO'];QJT7/F=Q<#^3/;XTG !_IKT ?KD"J<? S[H77;Z*&7K)N&VN#>8R<3,0
M?,6.56?8[&?W*U^<J38X54X5'*+60'8NZG*GQ8).^\^^T_JS!^W<<JS&0??
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M:^7#C7Q[LDCG-S.Y_NRZD,IL=E84#:L52EJAA*1"^=>VSB8]X#\3WG(7ZS.
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MW^%^I+WM8]C5;K>?W68G^^:5.-='IR_6GZ3+=^B?OO@?4$L#!!0    ( %R
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M#U!+ 0(4 Q0    ( %R 1E8"SZHTMQ4  #.6   1              "  0
M  !A<G=R+3(P,C,P,C V+FAT;5!+ 0(4 Q0    ( %R 1E;I*#_I;P(  (D'
M   1              "  >85  !A<G=R+3(P,C,P,C V+GAS9%!+ 0(4 Q0
M   ( %R 1E8/TC(2D@H  !%A   5              "  808  !A<G=R+3(P
M,C,P,C V7VQA8BYX;6Q02P$"% ,4    " !<@$96^I^=2M\&   (,P  %0
M            @ %)(P  87)W<BTR,#(S,#(P-E]P<F4N>&UL4$L! A0#%
M  @ 7(!&5GG'@2.1&P  R@L! !H              ( !6RH  &%R=W(M,C R
H,S R,#9X.&ME>#DY,3$N:'1M4$L%!@     %  4 3 $  "1&      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
